PROVIDER PROFILE · NPI 1558576686
Liawaty HoMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,526
Unique beneficiaries
—
Total services
63,179
Distinct HCPCS
57
Medicare payment
$1.2M
Peer benchmark
Total Medicare services vs. 54 Hematology-Oncology providers in NV — above median (cohort median 126,412).
PRESCRIBING · PART D · 2024
Total Rx claims
774
Beneficiaries
—
Total drug cost
$1.9M
Distinct drugs
20
Brand share
16.9%
Top prescribed drugs
Anastrozole221 claims
Exemestane109 claims
Letrozole101 claims
Ibandronate Sodium42 claims
Cabozantinib S-Malate33 claims
QUALITY · MIPS · 2024
Final MIPS score
96.9
Quality
84.4
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.92%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$4K
Payment records
229
By payment type
Food and Beverage$4K
Education$68
Top paying entities
Food and Beverage$4K
Education$68
REFERRAL NETWORK
Where Liawaty Ho's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Quest Diagnostics Incorporated Clinical Laboratory · Las Vegas, NV | 100 | 1,465 |
| SUNRISE MOUNTAINVIEW HOSPITAL, INC. | 23 | 105 |
| TOUROUTOGLOU, NIKOLAOS | 19 | 436 |
| Dimitrios Diamandidis Medical Oncology · Las Vegas, NV | 14 | 245 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE